Copy Number
The putative cancer-associated PDGs driven by SCNAs in each cancer type were identified by four criteria: 1) located in a peak region of a significantly recurrent focal SNCA locus estimated by the genomic identification of significant targets in cancer (GISTIC2) algorithm, (q≤0.25); 2) altered with high frequency and large amplitude (G-score ≥0.1); 3) mRNA reliably detected in at least 10% of tumor specimens in the given cancer type (90th percentile of FPKM value ≥1); and 4) mRNA significantly and positively correlated with copy numbers (Pearson P-value less than 0.001).
| Showing page 291 |
first page | previous page | next page | last page |
| Overall_Gscore | No. of Cancer Types | ||||
| HGNC Symbol | Ensembl Gene ID | Amplification | Deletion | Amplification | Deletion |
| UBR7 | ENSG00000012963 | 0.00 | 0.31 | 0 | 1 |
| SMARCC2 | ENSG00000139613 | 0.00 | 0.00 | 0 | 0 |
| KCNG2 | ENSG00000178342 | 0.00 | 0.00 | 0 | 0 |
| EPHA5 | ENSG00000145242 | 0.00 | 0.00 | 0 | 0 |
| XPNPEP1 | ENSG00000108039 | 0.00 | 0.46 | 0 | 3 |
| EDEM2 | ENSG00000088298 | 0.00 | 0.00 | 0 | 0 |
| GDNF | ENSG00000168621 | 0.00 | 0.00 | 0 | 0 |
| CELA3A | ENSG00000142789 | 0.00 | 0.00 | 0 | 0 |
| MINK1 | ENSG00000141503 | 0.00 | 0.12 | 0 | 1 |
| AKR1A1 | ENSG00000117448 | 0.00 | 0.00 | 0 | 0 |
| MAPKAPK5 | ENSG00000089022 | 0.00 | 0.22 | 0 | 1 |
| SLC6A4 | ENSG00000108576 | 0.00 | 0.00 | 0 | 0 |
| NR2C1 | ENSG00000120798 | 0.00 | 0.00 | 0 | 0 |
| NELL1 | ENSG00000165973 | 0.00 | 0.00 | 0 | 0 |
| CBX5 | ENSG00000094916 | 0.00 | 0.00 | 0 | 0 |
| APPL2 | ENSG00000136044 | 0.00 | 0.00 | 0 | 0 |
| SLC9A8 | ENSG00000197818 | 0.12 | 0.00 | 1 | 0 |
| SETD7 | ENSG00000145391 | 0.00 | 0.00 | 0 | 0 |
| GRIN2B | ENSG00000273079 | 0.00 | 0.00 | 0 | 0 |
| TAP2 | ENSG00000204267 | 0.00 | 0.00 | 0 | 0 |
|
Showing page 291 |
first page | previous page | next page | last page |
Copyright © 2020 University of Pennsylvania. All Rights Reserved.